Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
The American Journal of Managed Care
|
February 20, 2025
Financial navigation: lessons from a program in practice
Natalie R Dickson, Samyukta Mullangi
JCO Oncology Practice
|
February 26, 2020
Insights From the Oncology Care First Proposal-Where We've Been and Where We're Going in Value-Based Care
Garrett Young, Stephen M Schleicher, Natalie R Dickson, et al.
Oncology (Williston Park, N.Y.)
|
February 1, 2024
Building Efficiency and Scaling With a Remote Genetic Counseling Program
Smita K Rao, L Johnetta Blakely, Kate Small, et al.
The American Journal of Managed Care
|
February 19, 2024
Why EOM participation was extremely low-and how to fix it
Aaron Lyss, Brian Kern, Joe Abrams, et al.
Journal of Comparative Effectiveness Research
|
May 13, 2022
Impact of clinical pathways on treatment patterns and outcomes for patients with non-small-cell lung cancer: real-world evidence from a community oncology practice
Natalie R Dickson, Karen D Beauchamp, Toni S Perry, et al.
Journal of Patient-Reported Outcomes
|
February 28, 2024
Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapy
Natalie R Dickson, Karen D Beauchamp, Toni S Perry, et al.
JCO Oncology Practice
|
April 19, 2021
Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case Study
Stephen M Schleicher, Basit Chaudhry, Natalie R Dickson, et al.
JAMA Network Open
|
February 21, 2025
Algorithm-Based Palliative Care in Patients With Cancer: A Cluster Randomized Clinical Trial
Ravi B Parikh, William J Ferrell, Yang Li, et al.
Clinical Breast Cancer
|
May 26, 2010
A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer
Denise A Yardley, Nancy W Peacock, Natalie R Dickson, et al.
Clinical Lung Cancer
|
June 10, 2005
A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancer
Suzanne F Jones, John G Kuhn, F Anthony Greco, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
The American Journal of Managed Care
|
February 20, 2025
Financial navigation: lessons from a program in practice
Natalie R Dickson, Samyukta Mullangi
JCO Oncology Practice
|
February 26, 2020
Insights From the Oncology Care First Proposal-Where We've Been and Where We're Going in Value-Based Care
Garrett Young, Stephen M Schleicher, Natalie R Dickson, et al.
Oncology (Williston Park, N.Y.)
|
February 1, 2024
Building Efficiency and Scaling With a Remote Genetic Counseling Program
Smita K Rao, L Johnetta Blakely, Kate Small, et al.
The American Journal of Managed Care
|
February 19, 2024
Why EOM participation was extremely low-and how to fix it
Aaron Lyss, Brian Kern, Joe Abrams, et al.
Journal of Comparative Effectiveness Research
|
May 13, 2022
Impact of clinical pathways on treatment patterns and outcomes for patients with non-small-cell lung cancer: real-world evidence from a community oncology practice
Natalie R Dickson, Karen D Beauchamp, Toni S Perry, et al.
Journal of Patient-Reported Outcomes
|
February 28, 2024
Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapy
Natalie R Dickson, Karen D Beauchamp, Toni S Perry, et al.
JCO Oncology Practice
|
April 19, 2021
Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case Study
Stephen M Schleicher, Basit Chaudhry, Natalie R Dickson, et al.
JAMA Network Open
|
February 21, 2025
Algorithm-Based Palliative Care in Patients With Cancer: A Cluster Randomized Clinical Trial
Ravi B Parikh, William J Ferrell, Yang Li, et al.
Clinical Breast Cancer
|
May 26, 2010
A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer
Denise A Yardley, Nancy W Peacock, Natalie R Dickson, et al.
Clinical Lung Cancer
|
June 10, 2005
A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancer
Suzanne F Jones, John G Kuhn, F Anthony Greco, et al.
Page
of 2